SCHEMBL16059336

SCHEMBL16059336

C1=CN2CNc3cccc(c32)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27601050 0.67 NOTUM (0.35)
SCHEMBL14281827 0.67 GAA (0.30)
SCHEMBL4837604 0.62 OXTR (0.31)
SCHEMBL8183764 0.59
SCHEMBL30468123 0.55 BRD4 (0.31)
SCHEMBL224635 0.53 ALOX5 (0.41)
SCHEMBL30334802 0.52 LMNA (0.43)
SCHEMBL121647 0.52 LMNA (0.43)
SCHEMBL23876704 0.52 ALOX5 (0.56)
SCHEMBL19475848 0.52 GAA (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970282-A1 TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS Incyte Corporation (US) 2016-01-20 EP disclosed
WO-2014143768-A1 TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS INCYTE CORPORATION (US) 2014-09-18 WO disclosed